
Kristin A. (Ammon) Shimano MD
HS Clinical Associate Professor University of California, San Francisco
Join to View Full Profile
505 Parnassus Ave# 0106San Francisco, CA 94143
Phone+1 415-476-3831
Dr. Shimano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2008 - 2010
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2008
- University of California (San Francisco)Residency, Pediatrics, 2003 - 2007
- Harvard Medical SchoolClass of 2003
Certifications & Licensure
- CA State Medical License 2005 - 2027
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children Start of enrollment: 2019 May 02
Publications & Presentations
PubMed
- High Melphalan Exposure Increases the Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.Christopher C Dvorak, Soohee Cho, Gabriel Salinas Cisneros, Christine S Higham, Julia Chu
Transplantation and Cellular Therapy. 2025-04-02 - Younger children with nonmalignant disease have increased incidence of mixed myeloid chimerism after allogeneic hematopoietic cell transplantation with busulfan-based ...Christopher C Dvorak, William C Temple, Gabriel Salinas Cisneros, Julia Chu, Lena E Winestone
Transplantation and Cellular Therapy. 2025-04-01 - 1 citationsWorking toward international consensus defining pediatric "refractory ITP".Candelaria O'Farrell, Amanda Bell Grimes, Taizo A Nakano, Robert J Klaassen, Michele P Lambert
Blood Advances. 2025-03-11
Abstracts/Posters
- Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic LymphohistiocytosisKristin A. Shimano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell TransplantsKristin A. Shimano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- American Society of Hematology, Dec. 7 to 10December 17th, 2024
- Eltrombopag Improves Outcomes in Kids with Newly Diagnosed ITPDecember 7th, 2024
- Putting Women & Children First to Optimize Their Hematology HealthDecember 7th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: